CDC says there are no U.S. hantavirus cases currently, 41 people being monitored

CDC says there are no U.S. hantavirus cases currently, 41 people being monitored


In this photo illustration Hantavirus samples are seen in Ankara, Turkiye on May 6, 2026.

Arman Onal | Anadolu | Getty Images

The U.S. Centers for Disease Control and Prevention said there are no hantavirus cases in the country as of Thursday, as it monitors 41 people for the virus.

The agency said the risk to the public remains low in the aftermath of an outbreak on a cruise ship.

The World Health Organization has reported 11 total cases of hantavirus linked to the outbreak, eight confirmed by lab testing, including three deaths.

The spread of the virus has sparked concerns about a potential global health crisis only a few years removed from the devastation of the Covid-19 pandemic. However, public health experts have stressed the risks from the outbreak are limited, and have cautioned that it likely will not cause a widespread health emergency.

The Andes strain of hantavirus associated with the outbreak, unlike other illnesses including Covid, measles and the flu, does not spread easily between people.

Even so, more confirmed cases could emerge in the coming weeks because it has a long incubation period, according to experts.

Some public health experts have said the U.S. response to the spread of hantavirus, slowed by staffing cuts at the CDC and the Trump administration’s decision to leave the WHO, has exposed cracks in its readiness to handle another health crisis.

Choose CNBC as your preferred source on Google and never miss a moment from the most trusted name in business news.



Source

These three artworks could sell for 0 million each next week as May auctions begin
Business

These three artworks could sell for $100 million each next week as May auctions begin

A large-scale Jackson Pollock drip painting titled, “Number 7A, 1948.” Crystal Lau | CNBC A version of this article first appeared in CNBC’s Inside Wealth newsletter with Robert Frank, a weekly guide to the high-net-worth investor and consumer. Sign up to receive future editions, straight to your inbox. Nearly $2 billion worth of art will come up […]

Read More
Biogen advances Alzheimer’s drug to late-stage trial despite disappointing data
Business

Biogen advances Alzheimer’s drug to late-stage trial despite disappointing data

A Biogen facility in Cambridge, Massachusetts. Brian Snyder | Reuters Biogen plans to advance an experimental drug for Alzheimer’s disease to late-stage testing despite disappointing mid-stage trial data, the company said Thursday. Biogen said its experimental drug that targets tau, a protein associated with the memory-robbing disease, failed to show better responses at higher doses. […]

Read More
Wealthy donors stand to win double tax benefit if ‘Trump Accounts’ allow stock donations
Business

Wealthy donors stand to win double tax benefit if ‘Trump Accounts’ allow stock donations

President Donald Trump onstage at the Treasury Department’s Trump Accounts Summit, in Washington, Jan. 28, 2026. Kevin Lamarque | Reuters A version of this article first appeared in CNBC’s Inside Wealth newsletter with Robert Frank, a weekly guide to the high-net-worth investor and consumer. Sign up to receive future editions, straight to your inbox. With the Trump […]

Read More